Literature DB >> 28582303

Tranexamic Acid Reduces Blood Loss in Craniosynostosis Surgery.

Nicole M Kurnik1, Lacey R Pflibsen, Ruth E Bristol, Davinder J Singh.   

Abstract

METHODS: The authors retrospectively reviewed 79 patients with craniosynostosis who underwent either bifrontal or biparietal-occipital calvarial vault remodeling before institution of tranexamic acid (TXA) administration (non-TXA group) and 35 patients after institution of TXA administration (TXA group). The patients were analyzed in 2 groups: all open calvarial vault remodeling patients (anterior and posterior) as a whole, and anterior vaults only as a subset analysis. Primary outcomes accessed were: total intraoperative blood transfused, postoperative blood transfused, and estimated blood loss (EBL). Secondary outcomes evaluated were length of stay in the pediatric intensive care unit and hospital length of stay.
RESULTS: When comparing all open calvarial vault remodeling patients, patients who received TXA required significantly less total blood transfusion during their operation (264 cc TXA group versus 428 cc non-TXA, P < 0.0001). Patients who received TXA required no blood transfusions postoperatively, compared with the non-TXA group, in which 45% of patients required postoperative blood transfusion. Weight-based EBL was also significantly lower in those patients receiving TXA (25 cc/kg in the TXA group versus 34 cc/kg in the non-TXA group [P = 0.0143]). All patients required transfusion intraoperatively. Pediatric intensive care unit length of stay was shorter in the TXA group, but there was no significant difference in total hospital length of stay. These findings also reached statistical significance when comparing only the anterior vault patients.
CONCLUSION: Intraoperative TXA administration has a correlation with reduced blood transfusion requirements, as well as EBL, in patients undergoing open calvarial vault remodeling. There were no adverse events related to TXA administration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28582303     DOI: 10.1097/SCS.0000000000003731

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  7 in total

Review 1.  [Prophylactic use of tranexamic acid in noncardiac surgery : Update 2017].

Authors:  J Waskowski; J C Schefold; F Stueber
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-01-24       Impact factor: 0.840

2.  Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis.

Authors:  Devon B O'Donnell; Sima Vazquez; Jacob D Greisman; Anaz Uddin; Gillian Graifman; Jose F Dominguez; Elizabeth Zellner; Carrie R Muh
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-10-17

3.  A Systematic Review of Tranexamic Acid in Plastic Surgery: What's New?

Authors:  Esteban Elena Scarafoni
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-23

4.  Optimal administration strategies of tranexamic acid to minimize blood loss during spinal surgery: results of a Bayesian network meta-analysis.

Authors:  Ziqin Cao; Qiangxiang Li; Jia Guo; Yajia Li; Jianhuang Wu
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 5.  Epsilon Aminocaproic Acid's Safety and Efficacy in Pediatric Surgeries Including Craniosynostosis Repair: A Review of the Literature.

Authors:  Alexander Bolufer; Takuma Iwai; Caroline Baughn; Alec C Clark; Greg Olavarria
Journal:  Cureus       Date:  2022-05-21

6.  Can Low-dose Tranexamic Acid Decrease Blood Loss and Transfusion Requirements in Total Knee Arthroplasty?

Authors:  Ozgur Senturk
Journal:  Cureus       Date:  2018-05-17

7.  Operative Time as the Predominant Risk Factor for Transfusion Requirements in Nonsyndromic Craniosynostosis Repair.

Authors:  Yehuda Chocron; Alain J Azzi; Rafael Galli; Nayif Alnaif; Jeffrey Atkinson; Roy Dudley; Jean-Pierre Farmer; Mirko S Gilardino
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.